Previous close | 310.54 |
Open | 310.54 |
Bid | 312.35 x 1000 |
Ask | 313.30 x 900 |
Day's range | 308.87 - 313.47 |
52-week range | 180.07 - 317.81 |
Volume | |
Avg. volume | 1,622,812 |
Market cap | 109.387B |
Beta (5Y monthly) | 1.31 |
PE ratio (TTM) | 84.15 |
EPS (TTM) | 3.71 |
Earnings date | 19 Jul 2023 - 24 Jul 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 312.26 |
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $310.54, marking a +0.88% move from the previous day.
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Intuitive Surgical's (NASDAQ:ISRG) stock is up by a considerable 35% over the past three months. Since the market...
InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare are included in this Analyst Blog.
Short-term macro challenges have not stopped these two companies from continuing to expand their businesses.
Last year may have scared investors away from the stock market. As the market recovers, some growth stocks with strong fundamentals may thrive. Two such revolutionary companies are virtual healthcare leader Teladoc Health (NYSE: TDOC), and robotic surgery leader Intuitive Surgical (NASDAQ: ISRG).
While no one can say when these choppy waters might subside, it's worth pointing out that the S&P 500 has still delivered a total return of 200% over the past 10 years and 67% over the last five. Intuitive Surgical (NASDAQ: ISRG) operates in one of the most non-cyclical industries on Earth -- the healthcare space. The company specializes in a very lucrative sub-sector of this industry: the surgical robotics market, a space that Grand View Research estimates is on track to be worth $18 billion by the year 2030.
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
NextEra Energy (NYSE: NEE) is a company well worth knowing about and adding to your watch list. The company bills itself as the world's largest utility company, and it can claim that in large part due to its ownership of the Florida Power & Light Company, which is itself "America's largest electric utility that sells more power than any other utility ..." There's a lot to like, or love, about NextEra Energy.
Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical (ISRG) outperforms the industry and the S&P 500 Index due to its strength in robotics.
Excluding his own Berkshire Hathaway, the answer would almost certainly be Apple (NASDAQ: AAPL). Buffett has invested more heavily in Apple than any other stock, by far. A little under half of your initial $2,500 would allow you to buy seven shares of Apple at the current price.
After a terrible 2022, the Nasdaq has come roaring back in 2023. In April the index traded flat as fears of a recession offset better-than-expected earnings reports from big tech stocks, but some top Nasdaq stocks jumped double digits. Keep reading to see the three top-performing stocks from the Nasdaq-100 in April to see if any of them are worth buying.
With 28 years (and counting) of development and expansion, Intuitive Surgical (NASDAQ: ISRG) has built quite a name for itself in the robotic-surgery market. Its state-of-the-art da Vinci Surgical Systems enable doctors to perform all sorts of minimally invasive surgeries (MIS). While the pandemic did have a short-term negative impact on elective procedures, Intuitive's revenue and net profits still managed to increase at a rapid pace over the past five years (see chart below).
Christopher Ruane reveals a duo of growth shares that are on his buy list... if he can purchase them at what he thinks is a good price. The post 2 growth stocks on my buy list appeared first on The Motley Fool UK.
Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.
Key Insights Institutions' substantial holdings in Intuitive Surgical implies that they have significant influence over...
The launch of OpenAI's ChatGPT and the rapid expansion of its user base (100 million active monthly users in January) triggered an intense race in the tech sector to rapidly explore and commercialize AI capabilities. Ark Investment Management's Big Ideas 2023 report claims that AI software can earn up to $14 trillion in revenues by 2030. Instead, opting for well-established companies with proven AI technologies can be an excellent way to tap into the $14 trillion AI revolution.
Shares of Intuitive Surgical (NASDAQ: ISRG) rose by 17.9% in April 2023, according to data from S&P Global Market Intelligence. The gains were driven by a surprisingly strong earnings report, followed by a flood of bullish analyst notes. The company behind the da Vinci line of robotic surgery systems beat Wall Street's expectations soundly in the first quarter of 2023.
Virtual healthcare company Teladoc Health (NYSE: TDOC) experienced some exceptional gains during the worst of the pandemic. When the pandemic subsided and hospitals reopened, investors expected telehealth services would no longer be in demand and dumped the company's stock, causing it to plummet. Teladoc, on the other hand, is demonstrating that it can not only survive but thrive in the post-pandemic market.
Amid an uncertain macroeconomic environment, Qiagen's (QGEN) first-quarter results reflect an impressive organic top line, led by strength in non-COVID-19 product groups.
Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the first quarter.
Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.
When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make...